Deutsche Bank AG Purchases 58,282 Shares of Oscar Health, Inc. (NYSE:OSCR)

Deutsche Bank AG boosted its position in Oscar Health, Inc. (NYSE:OSCR) by 51.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 172,127 shares of the company’s stock after purchasing an additional 58,282 shares during the quarter. Deutsche Bank AG owned approximately 0.07% of Oscar Health worth $2,313,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Tower Research Capital LLC TRC increased its holdings in shares of Oscar Health by 171.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock valued at $89,000 after acquiring an additional 4,185 shares in the last quarter. KBC Group NV increased its holdings in shares of Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after acquiring an additional 2,555 shares in the last quarter. Alberta Investment Management Corp bought a new position in shares of Oscar Health during the fourth quarter valued at $138,000. Virtu Financial LLC bought a new position in shares of Oscar Health during the fourth quarter valued at $140,000. Finally, Potentia Wealth bought a new position in shares of Oscar Health during the fourth quarter valued at $141,000. Institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Wall Street Zen cut Oscar Health from a “buy” rating to a “hold” rating in a research report on Thursday. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Oscar Health has a consensus rating of “Hold” and an average price target of $20.08.

Oscar Health Trading Down 3.4%

Oscar Health stock opened at $14.36 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The stock has a market capitalization of $3.60 billion, a PE ratio of -717.44 and a beta of 1.75. The business’s fifty day moving average is $13.63 and its 200 day moving average is $14.61.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion for the quarter, compared to analysts’ expectations of $2.87 billion. During the same period last year, the firm posted $0.62 earnings per share. Oscar Health’s revenue was up 42.2% compared to the same quarter last year. On average, sell-side analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insiders Place Their Bets

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now directly owns 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 24.39% of the company’s stock.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.